基因疗法治疗先天性免疫缺陷:过去的进展,目前的状况和未来的方向
Robert Torrance1, Kate Orf1,2, Thomas A Fox1,2
1UCL Institute of Immunity and Transplantation, UCL, London NW3 2PP, United Kingdom.
概括
基因疗法 (GT) 提供了一种独立于捐赠者的安全和有效的治疗方法,用于治疗先天性免疫错误 (IEI),纠正遗传缺陷. 本综述强调了四十年的进展,当前的基因编辑技术,以及IEI治疗的未来方向.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 医学科学 医学科学 医学科学
背景情况:
- 免疫的先天性错误 (IEI) 是一种罕见的遗传性疾病,导致严重的感染,自身免疫和恶性瘤.
- 全基性造血干细胞移植 (alloHSCT) 是主要的治疗方法,但需要捐赠者并带有风险.
- 自主基因疗法 (GT) 使用患者自己的细胞,避免了供体需求和alloHSCT并发症.
研究的目的:
- 在过去的40年中,审查基因疗法 (GT) 对免疫的先天性错误 (IEI) 的进展.
- 描述当前用于纠正IEI的基因编辑技术.
- 检查IEI基因疗法的进展,挑战和未来方向.
主要方法:
- 对IEI的基因疗法进行临床前和临床研究的审查.
- 对IEI纠正的基因编辑技术 (例如CRISPR-Cas9) 的分析.
- 讨论挑战和新兴的体内方法.
主要成果:
- 基因疗法在纠正各种IEI方面已经证明了安全性和有效性.
- 基因编辑技术可以精确地纠正IEI中的遗传缺陷.
- 已经取得了重大进展,正在进行开发和新兴的体内战略.
结论:
- 自主基因疗法是IEI的alloHSCT的安全有效替代方案.
- 基因编辑技术正在推动IEI的治疗.
- 未来的发展,包括体内基因疗法,为更广泛的IEI治疗提供了希望.
相关概念视频
Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Microorganisms in Medicine and Therapeutics
1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
What is Genetic Engineering?
80.4K
Overview
80.4K
Development of Immunocompetence
1.0K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.0K
Immunodeficiency Diseases
2.5K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
2.5K
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K


